Leaf Expression promises rich harvest for drug industry
Company's multimillion pound purpose-built facility becomes fully operational amidst growing interest worldwide in its potentially game-changing plant transient expression technology, Hypertrans.
Leaf Expression Systems, a contract biopharmaceutical development business specialising in plant-based expression of proteins, metabolites and complex natural products, has announced that life sciences veteran Simon J.Y Saxby has joined the company as Chief Executive Officer. The appointment comes as Leaf Expression System’s multi-million pound purpose-built facility on the Norwich Research Park becomes fully operational amidst growing interest worldwide in its potentially game-changing plant transient expression technology, Hypertrans.
Simon has over 30 years of global international experience in life sciences, including his recent roles as CEO of Stratophase and as Project Director for the design and build of the UK Government’s Cell and Gene Therapy Catapult commercial-scale GMP Manufacturing Centre in Stevenage.
Dr Steven Powell, Executive Director of Leaf Expression Systems, commented: “We are pleased to be able to attract someone with as extensive and deep experience as Simon to drive Leaf Expression Systems to the next stage in its scientific and commercial development. Leaf is a unique and innovative addition to the biopharmaceutical landscape and we look forward to a period of rapid growth.”
Simon Saxby added: “I am delighted to be joining the Leaf Expression Systems team at such an important time in the growth of the business. Leaf’s revolutionary Hypertrans technology offers a solution to the significant financial pressures being experienced by the global life sciences industry to lower the costs of new diagnostics and therapeutics, by providing an innovative way of rapidly and cost-effectively producing proteins, vaccines and complex biomolecules. Our goal is now to establish Leaf Expression Systems as a partner of choice by adding real value to the research and development programmes of our clients across the globe.”
Using tobacco plants, Leaf Expression Systems' Hypertrans expression system can rapidly and safely produce not only vaccines (polio, Blue Tongue and Zika), enzymes and antibodies but also complex molecules. They have the potential to create new biochemical pathways for bioactive chemicals such as anti-cancer drugs.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance